CICC
GILD icon

Capital Investment Counsel (Colorado)’s Gilead Sciences GILD Stock Holding History

Capital Investment Counsel (Colorado)’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.26M Buy
49,570
+666
+1% +$87.8K 0.77% 53
2026
Q1 		$6.82M Sell
48,904
-12
-0% -$1.68K 0.93% 45
2025
Q4 		$6M Sell
48,916
-58
-0.1% -$7.05K 0.83% 53
2025
Q3 		$5.44M Sell
48,974
-478
-1% -$54.3K 0.8% 54
2025
Q2 		$5.48M Sell
49,452
-3,337
-6% -$355K 0.85% 53
2025
Q1 		$5.92M Sell
52,789
-3,053
-5% -$315K 0.98% 44
2024
Q4 		$5.16M Sell
55,842
-229
-0.4% -$20.6K 0.86% 55
2024
Q3 		$4.7M Buy
56,071
+1,717
+3% +$131K 0.81% 62
2024
Q2 		$3.73M Buy
54,354
+1,493
+3% +$99.6K 0.73% 60
2024
Q1 		$3.87M Buy
52,861
+16,536
+46% +$1.27M 0.83% 53
2023
Q4 		$2.94M Buy
+36,325
New +$2.83M 1.11% 44

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Swiss National Bank
Swiss National Bank Zurich, Switzerland $191B AUM 45.21% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Capital Investment Counsel (Colorado)'s GILD Position: Q2 2026 in Review

Capital Investment Counsel (Colorado) increased its Gilead Sciences (GILD) stake by 1.4% in Q2 2026, buying an estimated $87.8K and bringing the position to 49,570 shares worth $6.26M. The position accounts for 0.77% of the portfolio, ranked #53.

Capital Investment Counsel (Colorado) first reported a position in GILD in Q4 2023 and has held it in 11 quarters since. The position peaked at $6.82M in Q1 2026. 1,513 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Capital Investment Counsel (Colorado) held 49,570 shares of Gilead Sciences worth $6.26M as of Q2 2026.
  • Capital Investment Counsel (Colorado) bought 666 Gilead Sciences shares in Q2 2026, an estimated $87.8K.
  • Gilead Sciences made up 0.77% of Capital Investment Counsel (Colorado)'s portfolio in Q2 2026, its #53 holding.
  • Capital Investment Counsel (Colorado) first reported a position in Gilead Sciences in Q4 2023 and has held it in 11 quarters since.
  • Capital Investment Counsel (Colorado)'s Gilead Sciences position peaked at $6.82M in Q1 2026.
  • 1,513 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Capital Investment Counsel (Colorado)'s 13F filing for Q2 2026, filed 15 Jul 2026.